Summit Therapeutics

Summit Therapeutics OCF Margin

The Operating Cash Flow Margin of Summit Therapeutics (SMMT) as of Nov 22, 2026 is -5,856.34 %. In the previous year, Operating Cash Flow Margin was -4,010.50 % — a change of 46.03% (lower).

OCF Margin

-5,856.34 %

YoY

46.03%

Last updated:

Operating Cash Flow Margin of Summit Therapeutics is 2022 -5,856.34 % . Operating Cash Flow Margin of Summit Therapeutics was 2021 -4,010.50 % . It decreases by 46.03% lower compared to the previous year.

The Summit Therapeutics OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2016
527.83 USD
Jan 1, 2017
-133.54 USD
Jan 1, 2018
-61.50 USD
Jan 1, 2019
-2,805.41 USD
Jan 1, 2020
-5,594.19 USD
Jan 1, 2021
-4,010.50 USD
Jan 1, 2022
-5,856.34 USD
The Summit Therapeutics OCF Margin history
YEAROCF MarginYoY
-5,856.34 %+46.03%
-4,010.50 %-28.31%
-5,594.19 %+99.41%
-2,805.41 %+4,461.68%
-61.50 %-53.95%
-133.54 %-125.30%
527.83 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

Operating Cash Flow Margin of Summit Therapeutics is -5,856.34 % in 2022.

Operating Cash Flow Margin of Summit Therapeutics changed from -4,010.50 % to -5,856.34 %, representing a 46.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Summit Therapeutics with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Summit Therapeutics

All Key Metrics — Summit Therapeutics